1. Most Discussed
  2. Gainers & Losers
GTG 1.1¢

GTG - Information a little old, but some points still relevant and interesting .....

  1. WAZDJ

    100 Posts.


    BREVAGen positions Genetic Technologies as a natural takeover target: In June 2013, NASDAQ listed Myriad Genetics received an adverse court ruling from the US Supreme Court regarding the company’s intellectual property. The ruling regarding Myriads hereditary breast cancer genetic test may have removed Myriad’s existing BRCA testing monopoly, although this is being disputed through the US courts. Myriad is understood to be looking to build its competitive advantage in the breast cancer testing arena by including a broad assessment of genetic markers in their tests. Myriad may consider acquiring Genetic Technologies in order to gain access to a novel, complementary test with growing sales that Key Opinion Leaders (KOL) recognise as having significant clinical utility.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.